This retrospective observational study evaluates postoperative pain outcomes in patients undergoing elective mastectomy who received systemic analgesia, rhomboid intercostal block (RIB), or combined rhomboid intercostal block with deep parasternal intercostal plane block (RIB + DPIPB). Medical records from October 2024 to October 2025 will be reviewed. Primary outcomes include pain scores within the first 24 hours, with secondary outcomes including opioid consumption, additional analgesic requirements, patient satisfaction, and early postoperative complications. All data will be analyzed retrospectively and anonymously.
Study Type
OBSERVATIONAL
Enrollment
66
Systemic Analgesia: Postoperative pain was managed using standard systemic analgesic medications as part of routine clinical care. Rhomboid Intercostal Block (RIB): Postoperative analgesia was provided using an ultrasound-guided rhomboid intercostal block performed as part of routine clinical practice. RIB + Deep Parasternal Intercostal Plane Block (DPIPB): Postoperative analgesia was provided using a combination of ultrasound-guided rhomboid intercostal block and deep parasternal intercostal plane block as part of routine clinical care.
Istinye Üniversity
Istanbul, Merkez Mahallesi, Turkey (Türkiye)
Postoperative Pain Score (VAS)
Postoperative pain intensity assessed using the Visual Analog Scale (VAS) based on routinely recorded clinical data.
Time frame: Within the first 24 hours after surgery (postoperative 1, 6, 12, and 24 hours).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.